Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Yue, W., Abe, K., & Brouwer, K. L. R. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800100e · Cited by 45
Self-citationZhou, Y. F., Gottesman, M. M., & Pastan, I. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1450 · Cited by 42
A novel method for the determination of biliary clearance in humans
Ghibellini, G., Johnson, B. M., Kowalsky, R. J., Heizer, W. D., & Brouwer, K. L. R. (2004) · The AAPS Journal · doi:10.1208/aapsj060433 · Cited by 42
Self-citationMini Review on Molecular Modeling of P-Glycoprotein (Pgp)
Ha, S., Hochman, J., & Sheridan, R. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782194806 · Cited by 42
Tucker, G., Houston, J. B., & Huang, S. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00148-8 · Cited by 41
Self-citationCarrier, I., Julien, M., & Gros, P. (2003) · Biochemistry · doi:10.1021/bi034257w · Cited by 40
Buckman, S. J., Sm, H., & Murphy, S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100085 · Cited by 37
Michael, M., Thompson, M., Hicks, R. J., Mitchell, P. L. R., Ellis, A. G., Milner, A. D., di Iulio, J., Scott, A. M., Gürtler, V., Hoskins, J. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8496 · Cited by 37
Guhlmann, A., Krauss, K., Oberdorfer, F., Siegel, T., Scheuber, P. H., Müller, J., Csuk-Glänzer, B., Ziegler, S., Ostertag, H., & Keppler, D. (1995) · Hepatology · doi:10.1002/hep.1840210615 · Cited by 37
Self-citationLee, S., & Sinko, P. J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.002 · Cited by 35
Cebecauerová, D., Jirásek, T., Budisova, L., Mandys, V., Volf, V., Novotna, Z., Subhanová, I., Hřebı́ček, M., Elleder, M., & Jirsa, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.009 · Cited by 35
Kurnik, D., Sofowora, G. G., Donahue, J. P., Nair, U. B., Wilkinson, G. R., Wood, A. J. J., & Muszkat, M. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31818d8f28 · Cited by 31
Caki-1 Cells Represent an in vitro Model System for Studying the Human Proximal Tubule Epithelium
Glube, N. D., Gießl, A., Uwe Wolfrum, B., & Langguth, P. (2007) · Nephron Experimental Nephrology · doi:10.1159/000107804 · Cited by 30
Takekuma, Y., Kakiuchi, H., Yamazaki, K., Miyauchi, S., Kikukawa, T., Kamo, N., Ganapathy, & Sugawara, M. (2007) · PubMed · Cited by 27
Zhang, W., Li, J., Allen, S. M., Weiskircher-Hildebrandt, E. A., Huang, Y.-H., George, R. A., Fong, R. G., Owen, A. J., & Hidalgo, I. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023309 · Cited by 27
Pharmacogenetics of Membrane Transporters
Sissung, T. M., Gardner, E. R., Gao, R., & Figg, W. D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-205-2_4 · Cited by 26
Data-Based Mathematical Modeling of Vectorial Transport across Double-Transfected Polarized Cells
Bartholomé, K., Rius, M., Letschert, K., Keller, D. B., Timmer, J., & KEPPLER, D. O. R. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015636 · Cited by 24
Self-citationQuinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
Rameis, H. (1985) · PubMed · Cited by 24
Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study
de Vries, E. F. J., Doorduin, J., Vellinga, N. A., van Waarde, A., Dierckx, R., & Klein, H. C. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.01.005 · Cited by 20
Rytting, E., Bryan, J., Southard, M. Z., & Audus, K. L. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.020 · Cited by 19
In Vitro–In Vivo Scale‐up of Drug Transport Activities
Maeda, K., & Sugiyama, Y. (2006) · Wiley eBooks · doi:10.1002/9780470140505.ch19 · Cited by 14
Self-citationCaki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3
Glube, N. D., & Langguth, P. (2008) · Nephron Physiology · doi:10.1159/000115040 · Cited by 13
99mTc-HIDA Cholescintigraphy in Children with Dubin-Johnson Syndrome
Bujanover, Y., Bar–Meir, S., Hayman, I., & Baron, J. (1983) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-198305000-00017 · Cited by 13
Organic Anion–Transporting Polypeptides
Tirona, R. G., & Kim, R. B. (2006) · Wiley eBooks · doi:10.1002/9780470140505.ch5 · Cited by 7
Self-citationUrban, T. J., & Giacomini, K. M. (2006) · Wiley eBooks · doi:10.1002/9780470140505.ch2 · Cited by 6
Self-citation
Cited by
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
An atlas of genetic influences on human blood metabolites
The Multiple Tissue Human Expression Resource (MuTHER) Consortium, Shin, S.-Y., Fauman, E. B., Petersen, A.-K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., et al. (2014) · Nature Genetics · doi:10.1038/ng.2982 · Cited by 1,515
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationLöscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.